Zantac (ranitidine) is a popular medication used to treat heartburn and acid reflux. In September 2019, the U.S. Food and Drug Administration (FDA) issued a statement announcing that some ranitidine products, including Zantac, contained low levels of a probable human carcinogen called N-nitroso dimethylamine (NDMA). NDMA is a substance that can increase the risk of Cancer with prolonged exposure at high levels.

Following the FDA’s announcement, numerous Zantac users and their families filed a Zantac Cancer Lawsuit against the manufacturers of the drug, alleging that they developed cancer due to their use of Zantac. These lawsuits claimed that the manufacturers were aware of the potential NDMA contamination but failed to warn consumers adequately.

Why did the FDA issue a safety warning about Zantac (ranitidine)?

The FDA issued a safety warning about Zantac (ranitidine) due to concerns about the presence of a potential human carcinogen called N-nitroso dimethylamine (NDMA) in some ranitidine products, including Zantac.

NDMA is classified as a probable human carcinogen, which means it has the potential to cause cancer in humans if exposed to high levels over an extended period. It is an environmental contaminant that is found in various industrial processes, and it may also form as a byproduct of certain chemical reactions, including those that occur during the storage and breakdown of ranitidine.

The FDA recommended that consumers who were using over-the-counter ranitidine products should stop taking them and switch to alternative medications for heartburn and acid reflux. Patients who were prescribed ranitidine were advised to speak with their healthcare providers about suitable alternatives.

Why is N-nitroso dimethylamine (NDMA) in Zantac (ranitidine) dangerous?

In the case of Zantac, NDMA was found to be present in some ranitidine products due to the inherent instability of the ranitidine molecule. When exposed to certain conditions, ranitidine can break down and produce NDMA, which is a highly toxic and potentially cancer-causing substance.

Exposure to high levels of NDMA over an extended period can lead to increased cancer risks. It primarily affects the liver and other organs, potentially leading to the development of various types of cancer, including liver cancer, stomach cancer, kidney cancer, and other gastrointestinal cancers.

What types of cancer have been linked to Zantac (ranitidine) use?

The use of Zantac (ranitidine) has been linked to an increased potential risk of several types of cancer due to potential contamination with N-nitroso dimethylamine (NDMA). NDMA is classified as a probable human carcinogen, meaning it has the potential to cause cancer in humans if exposed to high levels over an extended period. The types of cancer that have been associated with NDMA exposure from Zantac use include:

• Stomach cancer (gastric cancer)
• Liver cancer (hepatocellular carcinoma)
• Colon cancer (colorectal cancer)
• Kidney cancer (renal cell carcinoma)
• Bladder Cancer

the research on the association between Zantac use, NDMA exposure, and cancer is ongoing. While some studies have indicated a potential link, more research is needed to fully understand the extent of the risk and the specific mechanisms involved.

Zantac Cancer Symptoms

Symptoms of these cancers can vary depending on the type and stage of cancer. It’s crucial to be aware of any unusual or persistent symptoms and seek medical attention promptly if you experience any of the following:

Stomach Cancer (Gastric Cancer) Symptoms:

• Persistent abdominal pain or discomfort
• Feeling full quickly after eating
• Unexplained weight loss
• Nausea or vomiting
• Difficulty swallowing

Liver Cancer (Hepatocellular Carcinoma) Symptoms:

• Abdominal pain or tenderness, especially in the upper right portion
• Unexplained weight loss
• Loss of appetite
• Jaundice (yellowing of the skin and eyes)
• Fatigue and weakness

Colon Cancer (Colorectal Cancer) Symptoms:

• Changes in bowel habits (diarrhea, constipation, or changes in stool appearance)
• Rectal bleeding or blood in the stool
• Abdominal pain or cramping
• Unexplained weight loss
• Fatigue

Kidney Cancer (Renal Cell Carcinoma) Symptoms:

• Blood in the urine (hematuria)
• Lower back pain on one side
• A mass or lump in the side or abdomen
• Unexplained weight loss
• Fatigue

How much is my Zantac cancer lawsuit worth in Illinois?

The value of a Zantac cancer lawsuit or any other personal injury lawsuit can vary significantly based on several factors, including the severity of the illness, the extent of damages, medical expenses, lost wages, pain and suffering, and other relevant factors.

To determine the potential worth of your Zantac cancer lawsuit in Illinois, you would need to consult with an experienced personal injury attorney. They will evaluate the details of your case, including your medical records, the extent of your injuries, and the circumstances surrounding your Zantac use. Keep in mind that lawsuits involving dangerous drugs like Zantac can be complex and involve multiple plaintiffs, which may lead to class-action or multidistrict litigation (MDL). The value of such cases can depend on the outcome of the litigation, the strength of the evidence, and the decisions made by the court.

Call Phillips Law Offices Today To File a Zantac Lawsuit

If you believe you have been affected by Zantac and are considering filing a Zantac cancer lawsuit, I recommend reaching out to a qualified Zantac cancer lawsuit attorney who specializes in dangerous drug litigation. A Phillips Law Offices attorney can help you with your medical bills while cancer diagnosis. They can provide you with legal options and advice tailored to your specific situation, explain the legal action, and guide you through the necessary steps to pursue your potential claim.

To get free consultation on your case, contact us now at (312) 598-0917 .

Also Reads:

What you need to know about Philips CPAP, BiPAP, and ventilator recalls

How Long After a Car Accident can delayed injury Appear?

What Is A Mesothelioma Prognosis?

The post Zantac Cancer Lawsuit Claims In Chicago, Illinois appeared first on Phillips Law Offices.